Recursion Pharmaceuticals Inc (RXRX) has gained 1.63% Thursday In Premarket Trading

Recursion Pharmaceuticals Inc (RXRX) is higher by Thursday morning, with the stock climbing 1.63% in pre-market trading to 11.25. RXRX's short-term technical score of 53 indicates that the stock has traded more bullishly over the last month than 53% of stocks on the market. In the Biotechnology industry, which ranks 98 out of 146 industries, RXRX ranks higher than 65% of stocks. Recursion Pharmaceuticals Inc has fallen 15.82% over the past month, closing at $15.00 on February 22. During this period of time, the stock fell as low as $10.37 and as high as $15.74. RXRX has an average analyst recommendation of Buy. The company has an average price target of $13.00.

RXRX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on RXRX!

See Full RXRX Report

Recursion Pharmaceuticals Inc has a Long-Term Technical rank of 51. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 49% of the market scoring higher. In the Biotechnology industry which is number 70 by this metric, RXRX ranks better than 70% of stocks.

Important Dates for Investors in RXRX:

-Recursion Pharmaceuticals Inc is set to release earnings on 2024-05-13. Over the last 12 months, the company has reported EPS of $-1.58. -We do not have a set dividend date for Recursion Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Recursion Pharmaceuticals Inc (RXRX)